ABSTRACT Two forms of the androgen receptor (AR) protein (apparent molecular masses, are present in human genital skin fibroblasts. The 87-kDa isoform (AR-A) contains an intact C terminus but lacks the normal N terminus found in the 11O-kDa isoform (AR-B).
Androgen action is mediated by a high-Affinity androgen receptor (AR) protein that is expressed in target tissues. Genetic defects that impair the function of this molecule in 46,XY males can cause a spectrum of phenotypic abnormalities, ranging from subjects with a complete female phenotype (complete testicular feminiz tion) to men with infertility or minor degrees of undervirilization (1) . In common with other members of the thyroid/steroid/retinoic acid receptor superfamily of ligand-activated transcription regulation factors, the AR protein contains an N-terminal segment that is involved in transactivation, a central DNA-binding domain, and a C-terminal hormone-binding domain (Fig. 1A ). Within this receptor family, diversity is generated in at least two ways: in some instances receptors that respond to the same ligand are encoded by different genes (e.g., retinoic acid and thyroid hormone receptors). In other cases, isoforms of the same receptor are derived from a single gene. In some instances, both mechanisms appear to operate. The different receptors and isoforms are believed to subserve different functions (far review, see refs. [3] [4] [5] [6] .
The AR, glucocorticoid receptor (GR), mineralocorticoid receptor (MR), and progesterone receptor (PR) proteins make up the GR-like family of nuclear steroid receptors, characterized by high sequence homology and the ability to interact with the same steroid hormone response element consensus sequence (5) . Each of the GR-like receptors is encoded by a unique single copy gene. Two naturally occurring hormone binding forms of PR have been identified (for review, see ref. 6 ). The PR-A isoform is an N-terminally truncated version of the full-length PR-B isoform. Several lines of evidence suggest that the PR-A and PR-B isoforms serve specific functions. Tora et al. (7) demonstrated promoter and cell-specific differences in the ability of PR-A and PR-B isoforms of the chicken to activate transcription of target genes, and two groups have shown that human PR-A and PR-B functions can be different, depending on cell and promoter context (8, 9) . Furthermore, PR-A can act under different conditions as an activator of gene transcription, a dominant repressor of activation by PR-B, or an inhibitor of GR-, AR-, or MR-mediated gene transcription (9, 28) .
The normal human AR, detected by immunoblot analysis with antibodies that recognize the N terminus, appears as an incompletely resolved doublet band migrating in SDS/PAGE with an apparent molecular mass of 110 kDa (10) . This AR doublet is also found in the human prostate tumor cell line LNCaP and is believed to reflect posttranslational phosphorylation of the 110-kDa AR gene product (11) . In a previous study (12) , we identified a mutation in the N-terminal region of the AR gene carried by a 46,XY phenotypic female (R776) with the syndrome of complete testicular feminization; this mutation introduces a premature termination codon in place of the normal AR codon for amino acid 60 (Fig. 1B) . These findings suggested that synthesis of the mutant 87-kDa AR protein is initiated at the first internal methionine residue (Met-188, Fig. 1C ).
In this report we show that normal genital skin fibroblasts contain both the full-length 110-kDa AR protein (termed AR-B) and an 87-kDa N-terminally truncated AR isoform (termed AR-A). Thus, a second member of the GR-like steroid receptor family exists in more than one hormonebinding form. The similarity between the AR isoforms and the more extensively studied PR isoforms raises the possibility that the A and B forms of AR may play distinct roles in the regulation of gene expression by androgens.
METHODS
Cell Culture and Extraction. Genital skin fibroblasts were grown to confluence, and soluble whole-cell extracts were prepared and stored as described (10) SDS/PAGE and Immunoblot Analysis. Western blots were prepared as described (10) except that SDS/PAGE was performed in "low bis" gels containiqg 7.5% (wt/vol) acrylamide, 0.05% NN'-methylenebisacryl~mide, and 0.1% SDS. Electrophoresis was continued until a prestained 49.5-kDa protein molecular mass marker (Bio-Rad) was within 1 cm of the bottom of the gel. Under these conjitions, the two forms of full-length AR, which migrate as an incompletely resolved 110-kDa doublet in standard 7.5% gels, are clearly resolved into two bands, well-separated from the 87-kDa form of AR, which appears to migrate as a single species. After transfer to nitrocellulose and incubation with anti-peptide antibodies, immunoreactive proteins were labeled with 125I-labeled antirabbit IgG and visualized by autoradiography. Blocking experiments were performed as before with antibodies preincubated with excess peptide antigen (13) . Relative levels of immunoreactive AR were estimated by densitometric analysis (10) . Molecular sizes were estimated by comparison with radiolabeled standard markers electrophoresed in the same gel (Rainbow molecular weight markers, Amersham). Polyclonal antibodies were obtained from rabbits U402, U407, and R489 that had been immunized, respectively, with the N-terminal, Int A, and C-terminal synthetic peptides, illustrated in Fig. 1B, and were purified on peptide affinity columns (13) .
Immunoadsorption of AR Proteins. Antibody-Sepharose conjugates were prepared by incubating affinity-purified anti-C-terminal, anti-N-terminal, or anti-Int A antibodies (0.4-0.6 mg of protein) with 0.1 g of CNBr-activated Sepharose, preswollen as directed by the manufacturer (Pharmacia LKB), in 2 ml of coupling buffer (0.25 M Na2CO3/0.5 M NaCl, pH 8.5) overnight at 4°C on an end-over-end rotator. Contrql CNBr-Sepharose was incubated without antibodies. The remaining active groups were blocked by incubation for 4 h at 4°C with 0.2 M glycine (pH 8). Coptrol Sepharose and antibody-Sepharose conjugates were washed twice with coupling buffer followed by 0.3 M KCl/0.1 M sodium acetate, pH 4, and resuspended in 2 ml of PBS (0.14 M NaCl/2.7 mM KCl/1.5 mM KH2PO4/8 mM Na2HPO4). Pellets obtained from 0.5-ml aliquots were incubated for 4 h on an end-overend rotator at room temperature with 150-/.l samples of high salt fibroblast extracts. The supernatant fraction containing free AR was separated by centrifugation for 5 min at 16,000 xg, recentrifuged, and diluted 1:1 with 2x SDS/PAGE loading buffer. The precipitate fraction containing immunoadsorbed AR was washed with three 1-ml portions of Tris-buffered saline (20 mM Tris HCl/0.14 M NaCl, pH 7.6) containing 0.1% Triton X-100 and with one 1-ml portion of PBS, resuspended in 300 ,ul of 1 x SDS/PAGE loading buffer, heated for 3 min in boiling water, and clarified by centrifugation prior to electrophoresis. (Fig. 3 Upper Left). The 87-kDa isoform is 7-15% of the total AR recognized by anti-Int A antibodies in these samples. The position of 87-kDa AR bands appears similar in all cases. Polymorphism in the length of the glutamine homopolymeric tract encoded by normal AR genes (see below) may account for variation in the positions of AR doublet bands located in the 110-kDa region of both immunoblots. The 87-kDa AR isoform is not recognized by anti-Nterminal antibodies (Fig. 3 Lower Left) . Furthermore, the reaction of 87-kDa and 110-kDa AR isoforms with these anti-peptide antibodies is specific and can be blocked by preincubating antibodies with excess peptide antigen (Fig. 3 Upper Right and Lower Right).
RESULTS
Changes (Fig. 1A) that varies from 11 to 31 glutamine residues in normal subjects (15) . Although the R776 mutant AR gene contains 21 CAG/CAA repeats, the polyglutamine tract is not present in the 87-kDa isoform initiated at Met-188 in R776 fibroblasts. AR genes carried by individuals with X chromosome-linked spinal and bulbar muscular atrophy (Kennedy syndrome) encode homopolymeric tracts with >40 glutamine residues (16) . Immunoblot analysis offibroblast strains from two such patients (strain 814, Fig. 4 ; strain 703, data not shown) reveals a decrease in the mobility of the full-length AR doublet compared to a normal control (strain 704), which has 20 CAG/CAA repeats but no change in mobility of the 87-kDa AR isoform. Mobility of the 87-kDa AR isoform from an androgen-resistant subject (strain 980) whose AR gene contains 15 CAG/CAA repeats also is normal, although the full-length AR doublet from this individual moves faster on SDS/PAGE. These results demonstrate that variation in the number of glutamine repeats influences mobility of the 110-kDa AR isoform but does not alter the mobility of the 87-kDa AR isoform, in keeping with the prediction that the shorter protein is initiated at a site downstream from the polyglutamine tract. antibodies. R776 fibroblast extracts containing 87-kDa AR (Fig. 5 Upper) or 704 fibroblast extracts containing both 87-kDa and 110-kDa AR isoforms (Fig. 5 Lower) were incubated with Sepharose-antibody conjugates to immunoabsorb reactive AR proteins or with unlinked Sepharose to determine the amount of nonspecific absorption. Insoluble Sepharose-antibody-AR protein complexes were separated from free AR proteins by centrifugation. The supernatant and precipitate fractions were subjected to immunoblot analysis with anti-Int A antibodies that recognize both AR isoforms. The 87-kDa and 110-kDa AR bands shown in Fig. 5 indicate the amount of free and immunoabsorbed AR in each treated sample compared to the amount of each isoform present in the original unfractionated sample.
Both AR isoforms remain in the supernatant after treatment with unlinked Sepharose as shown in Fig. 5 , lanes Control S. The faint 87-kDa and 110-kDa bands visible in lanes Control P probably represent nonspecific trapping of AR proteins in the precipitate. The 10-kDa AR is recognized by anti-N-terminal antibodies linked to Sepharose and the majority of this isoform appears in the precipitate (Fig. 5 Lower, lane Anti-N-Term P). As expected from previous results (12), the 87-kDa isoform does not react with anti-Nterminal antibodies and remains in the supernatant. Several faint bands are present in the precipitate obtained with anti-N-terminal antibodies linked to Sepharose and are also produced in the absence of fibroblast extracts (data not shown), presumably reflecting nonspecific reactivity of the anti-N-terminal antibodies used in this experiment.
Anti-Int A antibodies recognize both 87-kDa and 110-kDa ARs and immunoabsorption with anti-Int A antibodies linked to Sepharose shifts the majority of both isoforms to the precipitate fraction. Attempts to increase the amount of AR immunoabsorbed by adding more antibody-Sepharose conjugate to the reaction mixture were not informative because of the concomitant increase in nonspecific absorption by unlinked Sepharose in the control sample.
The 87-kDa AR band from R776 fibroblasts is present in both precipitate and supernatant fractions obtained with anti-C-terminal antibodies linked to Sepharose (Fig. 5 Upper). The same results are seen with both 87-kDa and 110-kDa AR isoforms produced by 704 fibroblasts (Fig. 5 Lower) . As previously observed, anti-C-terminal antibodies do not react with AR proteins as efficiently as the anti-N-terminal antibodies or anti-Int A antibodies (12, 13) . However, the observation that the 87-kDa AR isoform is recognized by anti-C-terminal antibodies in this experiment indicates that the immunoreactive C terminus of normal AR protein is present in the 87-kDa AR molecule and provides further evidence that the truncated AR protein present in normal genital skin fibroblasts is the same 87-kDa isoform produced by mutant R776 cells.
DISCUSSION
Two forms of the AR are present in normal human fibroblasts. The predominant AR isoform (AR-B; apparent molecular mass, =110 kDa) is predicted by the complete coding sequence of the human AR cDNA (2, (17) (18) (19) . It was first detected in our study (12) of the mutant AR gene from a patient with androgen resistance (R776). AR-A is recognized by anti-Int A antibodies and anti-C-terminal antibodies but not by anti-N-terminal antibodies. It is present at similar levels in R776 fibroblasts and in fibroblast strains from normal individuals. These findings suggest that AR-A is produced in genital skin fibroblasts by initiation of protein synthesis at the internal Met-188 residue of AR-B. This mechanism has also been proposed to account for a similar form of AR produced by in vitro translation of in vitrosynthesized AR mRNA (17) .
The two forms of human AR protein identified in this report show a striking resemblance in structure to the A and B isoforms of PR (for review, see ref. 6 ). PR-A is an N-terminally truncated variant of PR-B that may arise by translation initiation at an internal methionine codon of the PR mRNA (20) or by translation of a specific PR mRNA (21) . The ratio of PR-A to PR-B in different species varies widely. For example, PR-A is the predominant isoform in rat uterus (22) , equivalent amounts of PR-A and PR-B are found in chicken oviduct (23) and human breast cells (24) , and PR-B may be the only isoform in rabbit uterus (25) .
Several studies indicate that PR-A and PR-B isoforms are functionally and structurally distinct (7) (8) (9) 28 (9) . Functional differences between the A and B forms of human PR also extend to their activation by antiprogestins. Human PR-A is inactive in reporter gene assays when complexed to the antiprogestin mifepristone (RU 486), whereas PR-B is able to activate transcription in the presence of mifepristone (26) (27) (28) . In some contexts, PR-A can inhibit receptor-mediated gene transcription by PR-B (9, 28) and interfere with gene activation by GR, MR, and AR (9) . Neither stoichiometric amounts of PR-A nor the presence of a functional DNA-binding domain in the PR-A isoform are required for these inhibitory actions, suggesting the effects are mediated via sequestration of cell-specific cofactors.
The functional roles of the A and B isoforms of human AR remain to be elucidated. Both the genetic evidence of patient R776 and the abnormally low level of transactivation observed in CV1 cells cotransfected with the mouse mammary tumor virus-chloramphenicol acetyltransferase reporter gene and cDNA encoding the R776 mutant AR protein (12) indicate that AR-A by itself is not capable of mediating all androgen action. However, we do not know whether this truncated AR isoform can activate some reporter genes, whether it can function in other types of cells, whether it reacts with antiandrogens, or whether it can influence the ability of the full-length AR-B isoform to mediate gene transcription. Furthermore, it is not known whether the level of AR-A expression in some tissues or at different developmental stages may be higher than the roughly 10% oftotal AR expression observed in normal human genital skin fibroblasts. Additional studies are required to establish the functional significance and pattern of AR isoform expression.
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